´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ LMCE 2019 & 60Â÷ Ãß°èÇмú´ëȸ : 2019-09-27±³À°ÀÏÀÚ : 2019-09-27
±³À°Àå¼Ò : ºÎ»ê º¤½ºÄÚ 205È£ ¿Ü
±³À°ÁÖÁ¦ :
LMCE 2019 & 60Â÷ Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø
¿¬¶ôó : 02-795-9914
À̸ÞÀÏ :
kscp3@kams.or.kr ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 18 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í Á¤È¸¿ø 10¸¸¿ø ÁØȸ¿ø 8¸¸¿ø ºñȸ¿ø 25¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-27 205 (2F) 08:00~08:40 KS01: Next generation diagnostic probes for laboratory medicine Tahir Pillay(University of Pretoria South Africa)
±³À°½Ã°£ 09-27 205 (2F) 09:00~09:30 SY05: Standardization of lipoprotein testing Vincent Delatour(Laboratoire National de Métrologie et d)
±³À°½Ã°£ 09-27 205 (2F) 09:30~10:00 SY05: Nonfasting lipid profiles- are we there yet? Khushbu Patel(UT Southwestern Medical Center USA)
±³À°½Ã°£ 09-27 205 (2F) 10:00~10:30 SY05: Triglyceride test with or without free glycerol blanking Jinsook Lim(Chungnam National University Hospital Korea)
±³À°½Ã°£ 09-27 201-202 (2F) 08:30~08:45 SY06: POCT in India: Current Scenario and the road ahead Prasenjit Mitra(All India Institute of Medical Sciences India)
±³À°½Ã°£ 09-27 201-202 (2F) 08:45~09:00 SY06: Past, Present and Future of Point of Care Testing in Thailand Nisarat Opartkiattikul(Thai Society of Clinical Pathology Thailand)
±³À°½Ã°£ 09-27 201-202 (2F) 09:00~09:15 SY06: POCT : current status and future in Mongolia M. Oyundelger(Mongolian Association of the Laboratory Medicine Mongolia)
±³À°½Ã°£ 09-27 201-202 (2F) 09:15~09:30 SY06: Practical challenges related to Point-of-care testing Nguyen Minh Ha(Nguyen Tri Phuong Hospital Vietnam)
±³À°½Ã°£ 09-27 201-202 (2F) 09:30~09:45 SY06: POCT in Myanmar : Present and Future Prospects Wah Wah Aung(Ministry of Health and Sports Myanmar)
±³À°½Ã°£ 09-27 201-202 (2F) 09:45~10:00 SY06: POCT in Taiwan : current and the future Po-Ren Hsueh(National Taiwan University College of Medicine Taiwan)
±³À°½Ã°£ 09-27 201-202 (2F) 10:00~10:15 SY06: Present and Future of POCT in Korea Hyung-Doo Park(Sungkyunkwan University School of Medicine Korea)
±³À°½Ã°£ 09-27 201-202 (2F) 10:15~10:30 SY06: Implementation POCT in Indonesia Luci Liana(Fatmawati Hospital Indonesia)
±³À°½Ã°£ 09-27 203-204 (2F) 08:40~09:00 SY07: Post-management of in vitro diagnostic devices and monitoring of side effects Segu Kang(Ministry of Food and Drug Safety Korea)
±³À°½Ã°£ 09-27 203-204 (2F) 09:00~09:20 SY07: Experience in establishment of MFDS reference standards and their usage in laboratory Hee Jin Huh(Dongguk University College of Medicine Korea)
±³À°½Ã°£ 09-27 203-204 (2F) 09:20~09:40 SY07: Experience of MFDS standard material and unmet need Hae Joon Park(SD Biosensor Korea)
±³À°½Ã°£ 09-27 203-204 (2F) 09:50~10:15 SY07: IVD Authorazation Process Seung-Rel Ryu(Ministry of Food and Drug Safety)
±³À°½Ã°£ 09-27 203-204 (2F) 10:15~10:40 SY07: Introduction of IVD Productification Support Program Ji Hun Cha(Ministry of Food and Drug Safety)
±³À°½Ã°£ 09-27 205 (2F) 11:00~12:00 PL02: Immunoassay interferences and their impact on patient care Carmen L. Wiley(AACC USA)
±³À°½Ã°£ 09-27 205 (2F) 13:00~13:30 SY08: Fluid and imaging biomarkers toward the development of therapies for Alzheimer Takeshi Iwatsubo(The University of Tokyo Japan)
±³À°½Ã°£ 09-27 205 (2F) 13:30~14:00 SY08: Pre-analytical and Analytical Considerations for the Implementation of AD biomarkers in the Clinical Laboratory Alicia Algeciras-Schimnich(Mayo Clinic USA)
±³À°½Ã°£ 09-27 205 (2F) 14:00~14:30 SY08: Biomarkers of Alzheimer Ae Young Lee(Department of Neurology Chungnam National University College of Medicine Korea)
±³À°½Ã°£ 09-27 201-202 (2F) 13:00~13:40 SY09: Multiplex assay application for the diagnosis of autoimmune disease Marvin Fritzler(University of Calgary Canada)
±³À°½Ã°£ 09-27 201-202 (2F) 13:40~14:05 SY09: Soluble type immune regulatory molecule assays in the field of cancer immunotherapy Jong-Han Lee(Yonsei University Wonju College of Medicine Korea)
±³À°½Ã°£ 09-27 201-202 (2F) 14:05~14:30 SY09: Multiplex Ag/Ab assay for the diagnosis of infectious diseases Jaehyeon Lee(Chonbuk National University Medical School Korea)
±³À°½Ã°£ 09-27 203-204 (2F) 13:00~13:30 SY10: Accreditation of Surveyor Training Programme by the International Society for Quality in Health Care External Evaluation Association (IEEA) Lena Low(The Australian Council on Healthcare Standards Australia)
±³À°½Ã°£ 09-27 203-204 (2F) 13:30~14:00 SY10: Management and Education for surveyors in Korea Institute for Healthcare Accreditation Hyun Ji Baek(Korea Institute for Healthcare Accreditation Korea)
±³À°½Ã°£ 09-27 203-204 (2F) 14:00~14:30 SY10: Introduction of Inspector Training Program by LMF Jihyang Lim(The Catholic University of Korea College of Medicine Korea)
±³À°½Ã°£ 09-27 101-102 (1F) 13:00~13:30 SY11: Comparing the perceptions and opinions of clinicians and laboratory medicine physicians about new DRG, laboratory test utilization and quality incentive Yong-jun Choi(Department of Social and Preventive Medicine Hallym University College of Medicine Korea)
±³À°½Ã°£ 09-27 101-102 (1F) 13:30~14:00 SY11: Comparison of laboratory test quality between laboratories with or without participating in New DRG: analysis of KEQAS data Sollip Kim(Inje University Ilsan Paik Hospital Korea)
±³À°½Ã°£ 09-27 101-102 (1F) 14:00~14:30 SY11: Comparison the Laboratory Test Utilization after introduction of New DRG by analyzing the health insurance claim data Hyeongsu Kim(Department of Preventive Medicine School of Medicine Konkuk University Korea)
±³À°½Ã°£ 09-27 205 (2F) 15:00~15:30 SY12: RNA sequencing in leukemia research Zhaolei Zhang(University of Toronto Faculty of Medicine Canada)
±³À°½Ã°£ 09-27 205 (2F) 15:30~16:00 SY12: Single cell RNA sequencing for biomedical research Dave Tang(University of Western Australia Australia)
±³À°½Ã°£ 09-27 205 (2F) 16:00~16:30 SY12: Clinical application of RNA sequencing Seung-Tae Lee(Yonsei University College of Medicine Korea)
±³À°½Ã°£ 09-27 201-202 (2F) 15:00~15:40 SY13: International Consensus on ANA pattern (ICAP): Nuclear patterns and their clinical relevance Luis E.C. Andrade(Federal University of Sao Paulo Brazil)
±³À°½Ã°£ 09-27 201-202 (2F) 15:40~16:20 SY13: Cytoplasmic ICAP patterns and their clinical relevance Edward K.L. Chan(University of Florida USA)
±³À°½Ã°£ 09-27 201-202 (2F) 16:20~16:40 SY13: Current status for ANA reporting in Korea Kyeong-Hee Kim(Dong-A University College of Medicine Korea)
±³À°½Ã°£ 09-27 203-204 (2F) 15:00~15:30 SY14: Laboratory Leadership: A Critical Role Inside and Beyond the Laboratory Richard C. Friedberg(Baystate Medical Center USA)
±³À°½Ã°£ 09-27 203-204 (2F) 15:30~16:00 SY14: Comparison of CAP and LMF Accreditation Programs – a Viewpoint from an Inspected Laboratory Sang Hoon Song(Seoul National University College of Medicine Korea)
±³À°½Ã°£ 09-27 203-204 (2F) 16:00~16:30 SY14: Human Resouce Management Hwan Sub Lim(Seoul Clinical Laboratories Korea)
±³À°½Ã°£ 09-27 205 (2F) 17:00~17:40 KS02: Integration of genomics and artificial intelligence drives precision oncology Marilyn M. Li(University of Pennsylvania USA)